SG HealthCare Co., Ltd. (KOSDAQ:398120)
South Korea
· Delayed Price · Currency is KRW 3,160.00
+150.00 (4.98%)
At close: Dec 5, 2025
SG HealthCare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Operating Revenue | 16,478 | 16,105 | 27,779 | 25,499 |
| Other Revenue | - | - | -0 | -0 |
| Revenue | 16,478 | 16,105 | 27,779 | 25,499 |
| Revenue Growth (YoY) | -11.90% | -42.02% | 8.94% | - |
| Cost of Revenue | 12,320 | 10,968 | 20,687 | 19,344 |
| Gross Profit | 4,158 | 5,136 | 7,091 | 6,155 |
| Selling, General & Admin | 4,019 | 4,289 | 3,852 | 3,672 |
| Research & Development | 786.57 | 681.85 | 557.34 | 517.39 |
| Amortization of Goodwill & Intangibles | 0.41 | 1.62 | 1.46 | 1.45 |
| Other Operating Expenses | 5.17 | 4.07 | 5.93 | 8.74 |
| Operating Expenses | 5,852 | 5,809 | 4,844 | 4,396 |
| Operating Income | -1,693 | -673.1 | 2,248 | 1,759 |
| Interest Expense | -409.42 | -483.91 | -1,017 | -1,509 |
| Interest & Investment Income | 177.77 | 135.66 | 122.96 | 56.79 |
| Earnings From Equity Investments | - | - | -0.91 | -1.15 |
| Currency Exchange Gain (Loss) | 457.94 | 936.02 | 129.77 | 67.54 |
| Other Non Operating Income (Expenses) | -3,199 | -3,475 | 716.86 | -641.05 |
| EBT Excluding Unusual Items | -4,666 | -3,561 | 2,199 | -267.75 |
| Gain (Loss) on Sale of Investments | 23.19 | -10.27 | - | -1.36 |
| Gain (Loss) on Sale of Assets | -75.54 | -71.42 | - | 1.53 |
| Asset Writedown | -25.08 | -13 | -84.13 | - |
| Pretax Income | -4,743 | -3,655 | 2,115 | -267.57 |
| Income Tax Expense | -537.28 | -122.31 | 339.19 | 183.37 |
| Earnings From Continuing Operations | -4,206 | -3,533 | 1,776 | -450.94 |
| Minority Interest in Earnings | -43.67 | -14.42 | -9.22 | - |
| Net Income | -4,250 | -3,547 | 1,767 | -450.94 |
| Net Income to Common | -4,250 | -3,547 | 1,767 | -450.94 |
| Shares Outstanding (Basic) | 9 | 9 | 8 | 6 |
| Shares Outstanding (Diluted) | 9 | 9 | 8 | 6 |
| Shares Change (YoY) | -18.35% | 18.86% | 28.47% | - |
| EPS (Basic) | -473.45 | -386.39 | 228.74 | -75.00 |
| EPS (Diluted) | -473.45 | -386.39 | 228.74 | -75.00 |
| Free Cash Flow | -4,784 | -2,936 | -432.66 | -1,946 |
| Free Cash Flow Per Share | -532.94 | -319.76 | -56.01 | -323.67 |
| Gross Margin | 25.24% | 31.89% | 25.53% | 24.14% |
| Operating Margin | -10.28% | -4.18% | 8.09% | 6.90% |
| Profit Margin | -25.79% | -22.03% | 6.36% | -1.77% |
| Free Cash Flow Margin | -29.03% | -18.23% | -1.56% | -7.63% |
| EBITDA | -1,275 | -303.9 | 2,552 | 2,055 |
| EBITDA Margin | -7.74% | -1.89% | 9.19% | 8.06% |
| D&A For EBITDA | 418.26 | 369.2 | 303.78 | 295.63 |
| EBIT | -1,693 | -673.1 | 2,248 | 1,759 |
| EBIT Margin | -10.28% | -4.18% | 8.09% | 6.90% |
| Effective Tax Rate | - | - | 16.04% | - |
| Advertising Expenses | - | 188.65 | 267.8 | 354.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.